Condition: MMR Mutation · Small Bowel Adenoma · Small-bowel Adenocarcinoma · Sponsor: Assistance Publique - Hôpitaux de Paris
The impact of small bowel (SB) capsule endoscopy (CE) on the screening (followed by diagnosis and treatment) of (pre)neoplastic lesions of the small bowel in Lynch syndrome (LS) patients is unknown. The iCARE4Lynch study is a retrospective cohort of patients carrying a pathogenic variant of the DNA mismatch repair gene (MMR) (MLH1, MSH2, MSH6, PMS2, EPCAM) who had had at least one SBCE for screening of small bowel (pre)neoplastic lesions between January 1st 2000 and December 31 2024.
This description comes directly from the study's public registry record.
Xavier DRAY, MD PhD · +33 (0) 1 49 28 21 61 · xavier.dray@aphp.fr
Aymeric BECQ, MD · +33 (0) 1 49 81 23 55 · aymeric.becq@aphp.fr
Always discuss trial participation with your own doctor first.
| Center for Digestive Endoscopy, Saint-Antoine Hospital | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07472686